首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Endovascular Aneurysm Sealing (EVAS) and Chimney EVAS in the Treatment of Failed Endovascular Aneurysm Repairs
【24h】

Endovascular Aneurysm Sealing (EVAS) and Chimney EVAS in the Treatment of Failed Endovascular Aneurysm Repairs

机译:血管内动脉瘤密封(EVA)和烟囱EVA治疗失败的血管内动脉瘤修理

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To assess the technical success and clinical outcome of reinterventions using the Nellix Endovascular Aneurysm Sealing (EVAS) System to treat complications after endovascular aneurysm repair (EVAR). Methods: Fifteen consecutive patients (mean age 79 years; 14 men) with prior EVAR were treated with EVAS between March 2014 and December 2015 at 2 institutions. The failed prior EVARs included 13 bifurcated endografts, 1 bifurcated graft plus fenestrated cuff, and 1 tube endograft. Endoleaks were the predominant indications: type Ia in 10 and type III in 5 (3 type IIIa and 2 type IIIb). All patients presented with progressive aortic aneurysms (median 7.85-cm diameter; range 6.5-11). Eight patients were treated on an urgent or emergency basis (6 symptomatic aneurysms and 2 contained ruptures). All patients underwent Nellix relining of the failed stent-graft; 10 had chimney (Ch) procedures in combination with EVAS (chEVAS) because the proximal landing zones were inadequate. Results: Technical success was 100%. All endoleaks were successfully sealed, and no additional intervention was required. No further endoleak after EVAS or chEVAS was recorded. Endobag protrusion occurred in 1 case without sequelae. One elderly patient with ruptured aneurysm died from multiple organ failure 2 months postoperatively. One renal artery guidewire injury led to nephrectomy because of active bleeding. No reinterventions, aneurysm-related mortalities, graft thrombosis, endoleaks, or chimney graft occlusions were observed during a median follow-up of 8 months (range 3-24). Conclusion: The present preliminary experience demonstrates that the use of EVAS/chEVAS is feasible for treatment of failed EVAR. This technique may be used as bailout or an alternative treatment when other established methods are infeasible or not available.
机译:目的:评估使用Nellix血管内动脉瘤密封(EVA)系统在血管内动脉瘤修复后治疗并发症(EVAR)后治疗并发症的技术成功和临床结果。方法:十五名连续患者(平均年龄79岁; 14名男子)在2014年3月和2015年12月在2个机构的evas进行了治疗。未发生的先前evars包括13个分叉的内泌菌移植物,1分叉移植件加入袖带,1个管内涂物。 EndoLeaks是主要的指示:IA型和III型,5(3型IIIa和2型IIIB)。所有患者均呈现渐进式动脉瘤(直径7.85厘米;范围6.5-11)。八名患者迫切或紧急基础(6种症状动脉瘤和2个含有的破裂)治疗。所有患者都接受了裸颗裸粒子的后果移植物; 10有烟囱(CH)程序与EVAS(CHEVAS)组合,因为近端着陆区不足。结果:技术成功为100%。所有腹部均成功密封,不需要额外的干预。在记录Evas或Chevas之后没有进一步的螺旋凸。没有后遗症的1个案例发生了胚胎突起。一个具有破裂动脉瘤的老年人死于术后2个月的多器官衰竭死亡。一种肾动脉导管损伤导致肾切除因子,因为活跃出血。在8个月的中位随访期间,没有重新发明,动脉瘤相关的死亡率,接枝血栓形成,止血剂或烟囱移植闭塞。结论:目前的初步经验表明,使用EVAS / CHEVAS的使用对于治疗失败的EVAR是可行的。当其他既定方法不可行或不可用时,该技术可以用作救助或替代处理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号